# FDA 483 - Suzhou Xishan Zhongke Drug R&D, Co. Ltd. - May 10, 2024

Source: https://www.globalkeysolutions.net/records/483/suzhou-xishan-zhongke-drug-rd-co-ltd/61ab2cdc-2020-48ea-aa73-2bae6e4e5cd9

> FDA 483 for Suzhou Xishan Zhongke Drug R&D, Co. Ltd. on May 10, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Suzhou Xishan Zhongke Drug R&D, Co. Ltd.
- Inspection Date: 2024-05-10
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2024-05-10](https://www.globalkeysolutions.net/records/483/suzhou-xishan-zhongke-drug-rd-co-ltd/45af84ab-48eb-4ecf-aa90-c57445dfe402)

## Related Officers

- [Deborah A Greco](https://www.globalkeysolutions.net/people/deborah-a-greco/38e393b5-55c4-461c-a0b0-4937e0cbec37)
- [Zhu Cen](https://www.globalkeysolutions.net/people/zhu-cen/df7753a8-00d1-4566-83fb-6f2245a8873e)

Company: https://www.globalkeysolutions.net/companies/suzhou-xishan-zhongke-drug-rd-co-ltd/dc890450-dcf3-4418-9b62-8b22b6de1182

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd